Scouting, brokering, negotiation and on & off-site due diligence, including buy & sell side licensing, M&A and VC/Angel investments, ranging from $5,000 to $1.5bn

Technical feasibility and market opportunity assessment of pre-clinical and clinical stage product opportunities or technologies for Pharma/Biotech, Diagnostic and Device companies, as well as VCs and private equity investors, ranging from pre-seed stage to large-cap specialty pharma

Strategy development including positioning and key message development, indication and market segment prioritization as well as program development for pre-clinical and clinical stage assets and technologies